Gold vs US Dollar

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Cyclacel Pharmaceuticals Inc (CYCC)
Cyclacel Pharmaceuticals Inc (CYCC) Financials

CYCC Cyclacel Pharmaceuticals Inc

0.333

0.002 (0.60%)

21 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-53.982	-65.021	-32.685	-45.72	-47.672	-48.087	-61.063	-125.357
Return on Equity (%)	-72.436	-82.389	-40.44	-59.557	-55.258	-54.133	-81.1	-282.403
Return on Invested Capital (%)	-73.262	-47.185	-44.414	-62.084	-41.806	-55.338	-86.731	-273.873
Operating Margin (%)	-1633.926	N/A	-5750	N/A	N/A	N/A	N/A	-6083.571
Net Profit Margin (%)	-1422.42	N/A	-4992.667	N/A	N/A	N/A	N/A	-5418.095
Book Value Per Share	3.108	1.765	1.19	0.912	5.053	3.527	1.526	0.045
Earnings Per Share	-2.611	-1.204	-0.584	-0.626	-1.887	-1.807	-1.632	-1.679
Cash Per Share	3.598	1.939	1.364	0.058	4.266	3.46	1.399	0.249
Working Capital Per Share	3.127	1.773	1.195	0.904	5.011	3.374	1.298	-0.053
Operating Profit Per Share	0.184	N/A	0.012	N/A	N/A	N/A	N/A	0.031
EBIT Per Share	-3	-0.686	-0.672	-0.711	-1.471	-2.152	-1.976	-1.886
EBITDA Per Share	-3	-0.686	-0.672	-0.711	-1.471	-2.152	-1.976	-1.886
Free Cash Flow Per Share	-2.632	-1.205	-0.583	-0.627	-1.876	-1.808	-1.634	-1.681

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	4.26M	12M	12.5M	12.5M	6.25M	9.99M	12.54M	N/A

Key Stats and Ratios

Year End 31 December 2023	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	12.54M	12.54M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	-14827.586	N/A
Net Profit Margin (%)	N/A	N/A	N/A	N/A	N/A	N/A	-10158.621	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	2.08M
Price to Earnings Ratio	-0.09
Price to Sales Ratio	4.94
Price to Cash Ratio	0.61
Price to Book Ratio	3.42
Dividend Yield	-

Share Statistics

Shares Outstanding	6.29M
Average Volume (1 week)	286.58k
Average Volume (1 Month)	437.24k
52 Week Change	-90.12%
52 Week High	4.00
52 Week Low	0.32

More Ratios Coming Soon!

Cyclacel Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions